CHRISTIANNA MAYBERRY: Open Payments
NPI 1902290935 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,874 in 66 payments from 21 companies in 2025. Trend: 2023 $1,640 · 2024 $2,579 · 2025 $1,874
Food & beverage: $1,802Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $333 |
| Janssen Biotech, Inc. | 13 | $318 |
| UCB, Inc. | 6 | $209 |
| LEO Pharma Inc. | 3 | $202 |
| GENZYME CORPORATION | 3 | $96 |
| Galderma Laboratories, L.P. | 5 | $95 |
| Organon LLC | 5 | $78 |
| PFIZER INC. | 4 | $75 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
Products named: TREMFYA, RINVOQ, Bimzelx, DUPIXENT, ANZUPGO, SKYRIZI, CIBINQO, VTAMA.
Industry payments across MD — which companies pay providers there.
